Eikon Therapeutics, Inc. (EIKN)
7.26
-0.98
(-11.89%)
USD |
NASDAQ |
Oct 23, 16:00
7.24
-0.02
(-0.28%)
After-Hours: 20:00
Eikon Therapeutics Net Income (Quarterly) : -88.41M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -88.41M |
| March 31, 2026 | -82.96M |
| December 31, 2025 | -79.66M |
| Date | Value |
|---|---|
| June 30, 2025 | -105.21M |
| March 31, 2025 | -68.24M |
| December 31, 2024 | -64.92M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 31.50M |
| Alnylam Pharmaceuticals, Inc. | 164.49M |
| Anika Therapeutics, Inc. | 3.309M |
| Savara, Inc. | -40.23M |
| Vericel Corp. | 2.206M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 88.41M |
| EPS Diluted (Quarterly) | -1.633 |
| Enterprise Value | 113.76M |
| Earnings Yield | -90.63% |
| Normalized Earnings Yield | -90.63 |